Keywords: novartis, investing, heavily, sales, marketing, keep, up
Novartis investing heavily in sales and marketing to keep up with peers
Article | 18 February 2000
Having announced a reasonably healthy set of results for 1999 andposting an 11% rise in earnings (Marketletter February 21), Novartis of Switzerland has ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
